Moat Ross plan to sell securities of Kiniksa Pharmaceuticals International, plc under Form 144

Moat Ross filed Form 144 to notify SEC of plan to sell 1703 units of Kiniksa Pharmaceuticals International, plc securities around 2026-04-09, with aggregate market value of $79,513.00. The total outstanding units is 45900637.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 04/06/2026, sold 2367 units for $114989.00;